Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Moon Lake Immunotherapeutics Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $721 Billion
- Q3 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 229,029 shares of MLTX stock, worth $12.7 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
229,029
Previous 228,803
0.1%
Holding current value
$12.7 Million
Previous $10.1 Billion
14.78%
% of portfolio
1.6%
Previous 1.64%
Shares
4 transactions
Others Institutions Holding MLTX
# of Institutions
124Shares Held
58.2MCall Options Held
52.2KPut Options Held
38K-
Bvf Inc San Francisco, CA21.8MShares$1.2 Billion34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$470 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$165 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$153 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$129 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $2.04B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...